Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Nonalcoholic steatohepatitis (NASH)

Nonalcoholic steatohepatitis (NASH)

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Nonalcoholic steatohepatitis (NASH)

31 trials tracked for Nonalcoholic steatohepatitis (NASH).

31Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 24 Phase 1 4 Other / NA 3
  1. Phase 2 Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) Completed
  2. Phase 2 LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) Completed
  3. Phase 2 Phase 2a Study of HPG1860 in Subjects With NASH Completed
  4. Phase 2 Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) Completed
  5. Phase 2 Study of Gemcabene in Adults With FPLD Completed
  6. Phase 2 A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) Completed
Show 25 more trials
  1. Phase 2 Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers Completed
  2. Phase 2 The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis Completed
  3. Phase 2 A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects Completed
  4. Phase 2 The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease Completed
  5. Phase 2 Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH) Completed
  6. Phase 2 The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) Completed
  7. Phase 2 Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis Completed
  8. Phase 2 Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis Completed
  9. Phase 2 A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) Completed
  10. Phase 2 A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH Completed
  11. Phase 2 A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial Completed
  12. Phase 2 A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) Completed
  13. Phase 2 Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) Completed
  14. Phase 2 DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis Completed
  15. Phase 2 Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) Completed
  16. Phase 2 Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) Completed
  17. Phase 2 Spironolactone Therapy In Young Women With NASH Completed
  18. Phase 2 A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) Completed
  19. Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics Completed
  20. Phase 1 Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function Completed
  21. Phase 1 AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis Completed
  22. Phase 1 Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function Completed
  23. N/A Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14 Completed
  24. N/A Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials Completed
  25. N/A Tesamorelin Effects on Liver Fat and Histology in HIV Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.